NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Recruiting	Phase 1 / Phase 2	2026-05-19		NCT07595172

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu Hengrui Pharmaceutical Co., Ltd.	29
West China Hospital	359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
West China Hospital, Sichuan University	Chengdu	China	129

Clinical trials